Patent attorneys will now be able to search millions of patent publications, read file wrappers from the USPTO (United States Patent and Trademark Office), and compare USPTO examiners, all within ChatGPT and Claude. Read USPTO file wrappers for more info.
Fremont, California, November 17, 2026 – In October 2026, IP Author, Inc., the AI platform for patent drafting and prosecution, launched connectors that place its patent research and prosecution products directly into ChatGPT and Claude. The IP Author connector is in Anthropic’s Claude directory as an Anthropic-verified connector, and it is also available in ChatGPT. It’s designed to be interoperable with other AI assistants that support the Model Context Protocol (MCP), such as Microsoft Copilot, Grok, and Mistral’s Le Chat.
Many in-house IP teams and law firms now have general AI assistants as part of their everyday routines. When used independently, however, they generate answers from training data that might be outdated and might generate patent numbers or citations that don’t exist. The IP Author connector addresses this issue by enabling the assistant to fetch real-time information from IP Author’s patent corpus and US prosecution data during a conversation. The attorney poses a question in natural language, and the response is based on authentic documents that can be verified.
What patent professionals can do inside ChatGPT and Claude
Attorneys ask questions in plain English. The assistant picks the right IP Author tool and answers from real records, so every patent number, rejection, and date can be checked. Tasks that usually take hours or days, such as a first-pass prior art search, a competitive landscape, or a file history review, can be started in minutes.
Prosecution and office actions
- Know the examiner before you answer. Compare any two USPTO examiners on: grant rate, mix of rejections, art unit, average time to allowance, and interview-to-allowance ratio.
- Note how examiners have made similar arguments. Search millions of prior US office action rejection passages by type, e.g., abstract idea (section 101), obviousness (section 103), or indefiniteness (section 112) rejections.
- See the whole story of any US application in one place. Each office action and response, the arguments that carried the day, the references cited by applicant and examiner, and a claim-by-claim chronology of every amendment for estoppel analysis.
- Plan the answer. Get a strategy brief on an office action: the response options and likely outcomes, the statutory deadlines and precedent from similar rejections elsewhere.
Search and clearance
- Search millions of global patent publications, with one result per patent family and every result tied to a real publication number.
- Check whether an idea is new. Describe the invention and get the closest patents and research papers, ranked and explained.
- Check whether a product assesses the risks before a product launches. Run a guided freedom-to-operate review with ranked risks, open questions, and a downloadable Word, Excel, or PDF report.
- Build claim charts that find their own evidence. Name a patent and a product, and the assistant finds the datasheets, ranks the sources by reliability, maps each claim element, and flags any gap that needs more evidence instead of papering over it.
Drafting
- Turn a disclosure into a draft. Hand over an invention disclosure and get a full provisional or utility draft, with claims, specification and figures, as an editable Word document. Then ask it to review its own work like a skeptical partner.
Portfolio and strategy
- Map a technology in one prompt. Get a shareable interactive report showing who leads, who is accelerating, which patents anchor the field, and where nobody has filed yet.
- Check standards essentiality, for example, whether a patent is essential to 5G, with the reasons.
- Review a company’s portfolio, export the results to Excel, and download patent documents in bulk.
What the difference looks like. In a test published by IP Author in October, Claude was asked how NVIDIA secured the grant of US Patent No. 12,554,796. Using a standard web search, Claude located the published patent but could not retrieve or explain its prosecution history.
When connected to IP Author, however, Claude was able to trace the entire prosecution journey: an initial rejection under the abstract idea doctrine, a prior art rejection in November 2024, an examiner interview in June 2025, and finally, the allowance of a narrower Claim 1 in September 2025.
Requests can also be chained into a finished piece of work. For an office action, an attorney might ask for a summary of the file history, then what claim scope has already been given up, then what has worked with this examiner, and finally an outline of the response.
IP Author answers with its sources in view, so the attorney can check every point against the original documents.
The attorney stays in control. The guided workflows pause at key steps, such as the invention summary, search scope, filters, and shortlisted patents, so the attorney can confirm or change each one before the analysis moves on. For freedom to operate and evidence of use, IP Author also reads each patent’s prosecution history for estoppel, then runs a second, deliberately skeptical review that can only weaken a finding, never strengthen it. Finished reports can be downloaded in Word, Excel, or PDF.
Why IP Author built it
The idea came from watching how attorneys already work. “An avid IP Author user told us about his workflow. He runs a patent search in IP Author, then grabs the results and takes them to ChatGPT, runs some analysis there, then runs a modified search again in IP Author, and repeats,” said Samir Raiyani, CEO of IP Author. “So if people are spending more time on ChatGPT, we figured, why don’t we take IP Author to ChatGPT rather than making our users shuttle back and forth between the two. IP Author search results can be remixed by ChatGPT or Claude. You can riff with the chatbot and with IP Author together to derive new insights.”
Speaking after a Licensing Executives Society (LES) panel in Silicon Valley in November, Raiyani added: “As the robots improve, the enterprise also moves much faster, and the complexity of IP questions grows at the same pace. The only way patent attorneys and portfolio managers can handle this increased complexity is to combine human judgment with AI firepower.”
Availability
The IP Author connector has been available since its October launch. It can be added from the Claude directory, under the Legal and Data & analytics categories. ChatGPT users can simply search for IP Author in ChatGPT’s Plugins page and connect it. Other MCP-enabled assistants can join via mcp.ipauthor.com/mcp. Sign-in with an IP Author account is required. Set-up information and documentation is available at mcp.ipauthor.com/docs.
To learn more about IP Author’s patent drafting and prosecution platform, visit ipauthor.com.
Security and data handling
Users connect with their own IP Author account. Anything accessed or created with the connector is subject to the same ownership, security, and retention policies as the IP Author web app. Customer content is never used for training models, data is encrypted in transit and at rest, and the company holds SOC 2 Type II and ISO 27001:2022 certifications, IP Author says.
About IP Author
IP Author, Inc. is an AI platform for patent drafting and prosecution adopted by more than 1,000 patent professionals at law firms and in-house IP teams. Tools include patent drafting, responding to office actions, examiner analytics, prior art/freedom to operate, and European drafting support.
When connected to IP Author, however, Claude was able to trace the entire prosecution journey: an initial rejection under the abstract idea doctrine, a prior art rejection in November 2024, an examiner interview in June 2025, and finally, the allowance of a narrower Claim 1 in September 2025.
You may also like…
The biggest AI opportunity is addressing the work you don’t do
Most enterprise AI business cases start with one question – how much faster can we do the work we already do? It's a...
Patent expiry is no shield: Bayer wins Rivaroxaban infringement case in Russia
Bayer Intellectual Property GmbH obtained patent No. 2297415 in 2000 for Rivaroxaban, a medicine used to treat venous...
Is your foreign filing patent strategy stuck in 2010?
Ask any in-house IP team how they handle foreign patent filings, and the answer is usually some version of the same...











